Neuronetics, Inc.
- May 7, 2015 · D · $34,343,355 sold of $34,343,355 · 23 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Dec 3, 2014 · D · $9,073,110 sold of $15,000,000 · 23 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Jan 3, 2013 · D · $271,500 sold of $271,500 · 1 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- May 23, 2011 · D · $30,000,001 sold of $30,000,001 · 22 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Aug 21, 2009 · D · $30,000,000 sold of $30,457,500 · 17 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
Raised $34.3M from 23 investors (100% of the $34.3M target) as of the latest filing. Mark is listed as executive officer on 5 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.